A9543 Y90 ibritumomab, prescription
A-Codes
Also known as: Zevalin therapeutic, Y-90 ibritumomab
Yttrium Y-90 ibritumomab tiuxetan injection used therapeutically for treatment of B-cell lymphomas.
Clinical Context
Used in targeted radiotherapy for treatment of relapsed or refractory B-cell non-Hodgkin's lymphoma.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.